Background-Voltage-gated potassium (K ϩ ) channels encoded by KCNQ genes (Kv7 channels) have been identified in various rodent and human blood vessels as key regulators of vascular tone; however, nothing is known about the functional impact of these channels in vascular disease. We ascertained the effect of 3 structurally different activators of Kv7.2 through Kv7.5 channels (BMS-204352, S-1, and retigabine) on blood vessels from normotensive and hypertensive animals. Methods and Results-Precontracted thoracic aorta and mesenteric artery segments from normotensive rats were relaxed by all 3 Kv7 activators, with potencies of BMS-204352ϭS-1Ͼretigabine. We also tested these agents in the coronary circulation using the Langendorff heart preparation. BMS-204352 and S-1 dose dependently increased coronary perfusion at concentrations between 0.1 and 10 mol/L, whereas retigabine was effective at 1 to 10 mol/L. In addition, S-1 increased K ϩ currents in isolated mesenteric artery myocytes. The ability of these agents to relax precontracted vessels, increase coronary flow, or augment K ϩ currents was impaired considerably in tissues isolated from spontaneously hypertensive rats (SHRs). Of the 5 KCNQ genes, only the expression of KCNQ4 was reduced (Ϸ3.7 fold) in SHRs aorta. Kv7.4 protein levels were Ϸ50% lower in aortas and mesenteric arteries from spontaneously hypertensive rats compared with normotensive vessels. A similar attenuated response to S-1 and decreased Kv7.4 were observed in mesenteric arteries from mice made hypertensive by angiotensin II infusion compared with normotensive controls. Conclusions-In 2 different rat and mouse models of hypertension, the functional impact of Kv7 channels was dramatically downregulated. (Circulation. 2011;124:00-00.)
P rimary hypertension is characterized by raised total peripheral resistance caused by increased arterial tone. 1 Evidence suggests increased vascular tone during hypertension is a result of a more depolarized membrane potential, which has been associated with a rise in intracellular calcium (Ca 2ϩ ). 2, 3 As such, an understanding of the K ϩ channels that stabilize the resting membrane potential is crucial for delineating the pathogenesis of hypertension.
Clinical Perspective on p •••
KCNQ1-5 genes encode for voltage-gated K ϩ channels (Kv7.1 through Kv7.5, respectively) that have an established physiological role in neurons, 4 -7 cardiomyocytes, 8 cochlea, 9 and some epithelia. 10 There is now a growing appreciation that Kv7 channels are important regulators of smooth muscle contractility in rodent and human blood vessels. [11] [12] [13] In all blood vessels studied, KCNQ1 and KCNQ4 expression appears to dominate, 11,12,14 -18 although our laboratory has shown a truncated variant of KCNQ5 is also readily expressed. 15, 19 Modulation of these channels provokes profound changes in vascular smooth muscle membrane potential and consequently vascular tone. [13] [14] [15] [16] [17] 20 Thus, the nonselective Kv7.1 through Kv7.5 channel blockers linopirdine and XE991 produce membrane depolarization and concomitant vasoconstriction by enhancing Ca 2ϩ influx through voltagedependent calcium channels. 13, [15] [16] [17] [18] 21 Conversely, agents such as retigabine and S-1, which enhance Kv7.2-Kv7.5-mediated currents but not Kv7.1-mediated currents, [22] [23] [24] [25] hyperpolarize the membrane potential 16, 17, 20 and relax precontracted rodent or human arteries. 13, [15] [16] [17] [18] 20, 26 Kv7 channels have been identified as effective regulators of vascular smooth muscle contractility in various blood vessels from normotensive animals; however, there is no information about the distribution and function of these channels in hypertension. To that end, we used a range of structurally disparate modulators of Kv7 channels to eluci-date the functional impact of Kv7 channels in the thoracic aorta, third-order branches of the superior mesenteric artery, and coronary circulation of normotensive rats and spontaneously hypertensive rats (SHRs), as well as the mesenteric artery of normotensive mice and angiotensin II (Ang II)-induced hypertensive mice. These studies revealed a startling diminution in response to these activators in vessels from animal models of primary (SHR) and secondary (Ang IIinduced hypertensive mice) hypertension, which was associated with a redundancy of Kv7.4 channels. These findings point toward an important role for Kv7.4 channels in the pathogenesis of hypertension.
Methods
An expanded Methods section is provided in the online-only Data Supplement.
Experiments were performed on male 12-to 15-week-old Wistar rats and SHRs (Charles River UK Ltd) euthanized by cervical dislocation or on 6-month-old male apolipoprotein E-deficient (ApoE Ϫ/Ϫ )/C57Bl6 mice infused with Ang II (1 g/min Ϫ1 /kg Ϫ1 ) or saline (sham) for either 7 or 28 days euthanized by anesthetic overdose (1:1:2 Hypnorm:Hypnovel:water). The systolic blood pressure of the mice was measured by the tail-cuff plethysmography method (RTBP system, Harvard Apparatus Ltd). All experiments were performed either in accordance with the UK Animal 
Isometric Tension Recordings
Experiments were performed on segments (Ϸ2 mm) of second-order (mice) or third-order (rat) mesenteric artery, as well as rat thoracic aorta mounted in a myograph (Danish Myo Technology). Individual vessel segments were precontracted with 10 mol/L (mesenteric artery) or 3 mol/L (thoracic aorta) methoxamine, and a Kv7 channel activator was applied cumulatively from 0.1 to 30 mol/L. The equivalent vehicle (dimethyl sulfoxide) dilutions were applied contemporaneously. Changes in tension were recorded continuously by PowerLab and Chart software (ADInstruments).
The Langendorff-Perfused Heart
Male Wistar rats and SHRs (12 to 15 weeks old) were anesthetized with intraperitoneal injection of 50 mg/kg sodium pentobarbital and artificially ventilated, and heparin (1000 IU/mL) was injected intravenously into the femoral vein. A perfusion cannula was fixed in the aorta to allow retrograde perfusion with Krebs solution at 80 mm Hg, maintained at 37°C, and continuously oxygenated with 95% O 2 /5% CO 2 . The heart was then excised and mounted in a vertical Langendorff setup (Hugo Sachs-Harvard Apparatus GmbH). Bipolar ECG electrodes were placed around the heart. All recordings were interfaced by a 16-channel PowerLab system and recorded and analyzed with Chart software (ADInstruments). The heart was allowed to stabilize for approximately 45 minutes before any drugs were applied. All pharmacological agents applied to the heart were added to the perfusate.
Single-Cell Isolation
Third-order branches of mesenteric artery were cleaned of adherent connective tissue in physiological saline solution (in mmol/L: 6.0 KCl, 120 NaCl, 1.2 MgCl 2 , 2.0 CaCl 2 , 10.0 D-glucose, and 10.0 HEPES; pH was adjusted to 7.3 with NaOH), transferred to nominally Ca 2ϩ -free physiological saline solution supplemented with protease type X (0.5 mg/mL) and collagenase type IA (1.5 mg/mL; Sigma-Aldrich), and incubated at 37°C for 15 minutes followed by a 5 minute wash in Ca 2ϩ -free physiological saline solution at room temperature. Single cells were obtained by gentle agitation with a wide-bore pipette and stored at 4°C for use within 6 hours of isolation.
Electrophysiological Recordings
Electric recordings were made in nominally Ca 2ϩ -free physiological saline solution by use of the amphotericin B-perforated patch whole-cell recording technique in voltage-clamp mode. This solution was also supplemented with 1 mol/L paxilline to block largeconductance Ca 2ϩ -activated K ϩ channels (BK Ca ). 27 The firepolished patch pipettes had a resistance of 4 to 6 M⍀ when filled with pipette solution of the following composition (in mmol/L): 115 KCl, 6.0 NaCl, 10.0 HEPES, pH adjusted to 7.2 with KOH. Before the experiment, the pipette solution was supplemented with amphotericin B (200 mg/mL). The electric signals were recorded with a MultiClamp 700A patch-clamp amplifier (Axon Instruments). Electric signals were generated and digitized at 1 kHz with a Digidata 1322A (Axon Instruments). Voltage-clamp experiments were performed at room temperature. Cells were held at potential of Ϫ60 mV, and a 5-second conditioning step to Ϫ80 mV was used to augment voltage-gated K ϩ currents elicited by voltage steps, with a 10-mV increment from Ϫ80 to ϩ40 mV.
Quantitative Polymerase Chain Reaction
Similar to previous experiments, 13, 28 quantitative analysis of mRNA expression was determined with Brilliant II SYBR Green QPCR Master Mix (Stratagene) with the Mx3005P system (Stratagene). Primers 18, 29 (Table 1) were synthesized by Invitrogen. Ct (Cycle threshold) values were determined with MxPro QPCR software (Stratagene), and RNA abundance relative to the housekeeper gene ␤-actin was calculated with ⌬Ct. The fold-change in KCNQ gene expression between normotensive and SHR aorta was then calculated with 2
Ϫ⌬⌬Ct . 30 All appropriate controls were performed. 13, 28 
(ϩ) Indicates sense; (Ϫ), antisense.
Western Blot Analysis
Thoracic aorta and third-order mesenteric arteries from Wistar rats and SHRs and mesenteric arteries from 7-day Ang II-infused, 28-day Ang II-infused, and saline-infused (7 and 28 days) ApoE Ϫ/Ϫ / C57Bl6 mice were homogenized in 200 L of lysis buffer (in mmol/L: 20 Tris base, 137 NaCl, 2 EDTA, 1% NP40, 10% glycerol, pH 8, and 10 L/mL protease inhibitor cocktail; SigmaAldrich), incubated on ice for 15 minutes, centrifuged to remove cell debris, and denatured at 95°C for 5 minutes in the presence of sample buffer and reducing agent (Invitrogen). Samples were then loaded onto SDS-PAGE gels (4 -12% Bis-Tris, Invitrogen), subjected to electrophoresis, and then transferred onto a polyvinylidene fluoride membrane (Amersham Biosciences). The membrane was then probed with an anti-Kv7.4 IgG (1:200; Santa Cruz, sc-50417; previously optimized to determine an effective concentration [data not shown]). Protein bands were visualized with enhanced chemiluminescence (Thermo Scientific) and hyperfilm (Amersham Bioscience). The membrane was then washed in PBS-Tween (0.1%) and subsequently reprobed for ␤-actin (1:5000; Sigma-Aldrich, A1978) and visualized as above. All bands were quantified with Scion Image Beta 4.03 (NIH).
Statistical Analysis
In the normotensive rat, the Kv7 activators and vehicle (dimethyl sulfoxide) were compared at each concentration with a KruskalWallis test followed by a Mann-Whitney post hoc test. For the thoracic aorta and mesenteric artery data, a Bonferroni adjustment of probability values was then used to address the issue of multiple comparisons. For comparisons of the effects of each Kv7 activator in the normotensive and hypertensive animals, a Kruskal-Wallis test was used where appropriate, followed by a Mann-Whitney post hoc test. All Figures report data as meanϮSEM. All analyses used either GraphPad Prism 5 or InStat 3.0 software.
Drugs
Retigabine, S-1, and BMS-204352 were synthesized at NeuroSearch A/S. Linopirdine and XE991 were purchased from Sigma-Aldrich and Ascent Scientific, respectively.
Results

Functional Experiments on Normotensive Rats
The functional impact of Kv7 channels in the vasculature of normotensive rats was assessed with 3 structurally different agents (retigabine, S-1, and BMS-204352), which all enhance Kv7.2 through 7.5 but not Kv7.1. [22] [23] [24] Moreover, S-1 and BMS-204352 have a greater efficacy on Kv7.4 and Kv7.5 than on Kv7.2 or Kv7.3. 25, 31 Figure 1A shows that S-1 produced a concentration-dependent relaxation in the precontracted mesenteric artery, which was mirrored by application of BMS-204352 ( Figure 1B) . A Kruskal-Wallis test comparing the Kv7 activators and dimethyl sulfoxide at each concentration showed significance at 1, 3, 10, and 30 mol/L (PϽ0.05). Similar to a previous report, 26 retigabine also relaxed precontracted mesenteric arteries, albeit with less efficacy than S-1 or BMS-204352 (nϭ6 to 11; Figure 1B ). Figure 1C shows that the thoracic aorta was relaxed by Ͼ50% on application of 10 mol/L S-1, BMS-204352, and retigabine (Pϭ0.0013 according to the Kruskal-Wallis test; nϭ4 to 13). None of the Kv7 activators could relax contractions evoked by 60 mmol/L KCl (nϭ3) or methoxamine-induced contractions in the presence of the Kv7 blockers linopirdine or XE991 at 10 mol/L (data not shown). Overall, these data show that 3 structurally different Kv7 activators were effective relaxants of methoxamine-precontracted rat thoracic aorta and mesenteric artery.
The functional impact of Kv7 channels in intact coronary arteries has not yet been characterized. Consequently, we used the Langendorff heart technique to assess the effect of Kv7 activators on coronary flow. Figure 2A shows that coronary flow was enhanced considerably by 1 to 10 mol/L S-1, which was reversed on washout or by the subsequent application of 10 mol/L linopirdine. All 3 Kv7 activators increased coronary flow in a linopirdine-sensitive manner, with S-1 and BMS-204352 having considerable effects at low concentrations (Ͻ1 mol/L; Figure 2B ). The Kruskal-Wallis test comparing the effects of the Kv7 activators and dimethyl sulfoxide showed significant differences at all concentrations tested (probability values ranging from 0.037 to 0.023). No Figure 1 . Effect of Kv7 activators on arterial tone from normotensive rats. A, Representative effect of increasing concentrations of S-1 on small mesenteric arteries precontracted with 10 mol/L methoxamine (F). B, Concentration effect curves for all 3 Kv7 activators on small mesenteric arteries. Each point is the mean of 6 to 11 animals ϮSEM. C, Comparison of relaxant effect of 10 mol/L retigabine, S-1, and BMS-204352 on rat thoracic aorta precontracted with 3 mol/L methoxamine. Data are meanϮSEM (nϭ4 to 13 animals). *PϽ0.05, **PϽ0.01, and ***PϽ0.001 for differences between the effect of the Kv7 activator and its respective concentration of dimethyl sulfoxide (DMSO) by Mann-Whitney test with Bonferroni adjustment. significant changes were observed on heart rate or ECG morphology (data not shown), which suggests that the increase in coronary flow was due to artery vasodilation rather than a change in cardiac properties.
Functional Experiments on Spontaneously Hypertensive Rats
In contrast to the obvious relaxant effects of the Kv7 channel activators in blood vessels from normotensive animals, Figure 3 shows that S-1, BMS-204352, and retigabine were relatively ineffective in the mesenteric arteries (nϭ5 to 6) and thoracic aorta (nϭ5 to 11) from SHRs. This was not because the blood vessels were unable to relax as effectively or because the contraction was less reliant on Ca 2ϩ influx through voltage-dependent Ca 2ϩ channels, because the relaxation produced by 1 mol/L nicardipine was not different between normotensive rats and SHRs (96Ϯ1% and 98Ϯ0.5%, respectively, in aortas and 98Ϯ0.5% and 92Ϯ5% in mesenteric artery; nϭ3). Similarly, the relaxations produced by the ATP-sensitive K ϩ channel opener pinacidil (10 mol/L) were 100Ϯ0% and 100Ϯ0% in aortas from normotensive rats and SHRs, respectively (nϭ3). In addition to the reduced effectiveness of Kv7 enhancers, the ability of the Kv7 blockers XE991 (1 and 10 mol/L) and linopirdine (10 mol/L) to contract thoracic aortas from SHRs was completely abrogated, in contrast to the robust contractions evoked in aortas from normotensive rats ( Table 2 ). In the Langendorff studies, the potent effect of S-1 and BMS-204352 on coronary flow was attenuated considerably in the SHR heart. Application of 1 mol/L BMS-204352 and 10 mol/L S-1 only increased the coronary flow in the SHR heart by 5.3Ϯ3.1% (nϭ3) and 2.6Ϯ1.3% (nϭ3) compared with increases of 32.6Ϯ7.2% (Pϭ0.02) and 46.9Ϯ16% (Pϭ0.02) observed in the normotensive heart, respectively. Retigabine (10 mol/L) increased coronary flow by 12.4Ϯ1.6% (nϭ5) in the SHR heart compared with a 39.6Ϯ6.1% increase in the normotensive rat heart (Pϭ0.004). These data reveal a striking reduction in the functional contribution of Kv7 channels in the vasculature of SHRs.
Single-Cell Electrophysiology
Outward K ϩ currents were recorded in 29 myocytes from 5 normotensive rats and 31 myocytes from 5 SHRs. Myocytes had an average capacitance of 17.9Ϯ1.2 and 20.4Ϯ0.6 pF for normotensive rats and SHRs, respectively. No significant difference was observed in the density of the outward K ϩ current between the 2 animal groups. For instance, the current evoked by voltage steps to 40 mV was 10.5Ϯ1.5 pA/pF (nϭ29) and 12.9Ϯ0.8 pA/pF (nϭ31) for normotensive rats and SHRs, respectively. Incubation of the myocytes with 10 mol/L S-1 for 3 minutes resulted in a significant increase of the outward current in myocytes from normotensive animals (Figures 4Ai and Bi), which was significantly less than in myocytes from SHRs (Figures 4Aii and Bii) . This is reflected in the mean S-1-sensitive current shown in Figure  4C . Conversely, application of 10 mol/L XE991 reduced outward current in normotensive animals (Figures 4Di and Ei), whereas in myocytes from SHRs, no significant effect was observed (Figures 4Dii and Eii) . Hence, effects of both a Kv7 activator and blocker were attenuated in myocytes from SHRs.
Expression Profiles of KCNQ Subunits in Normotensive Rats and Spontaneously Hypertensive Rats
Quantitative polymerase chain reaction was undertaken to assess whether impairment of Kv7 function in the SHR vasculature was due to reduced expression of KCNQ genes. The difference in expression of KCNQ subunits from the thoracic aorta of SHRs compared with normotensive rats was calculated as the fold-change relative to ␤-actin by 2
Ϫ⌬⌬Ct . With this method of analysis, a fold difference of 1.0 represents no change. Expression of KCNQ1 through KCNQ3 (nϭ3 to 5) remained largely unchanged, whereas expression of KCNQ4 decreased 3.7-fold in SHR compared with normotensive rat thoracic aorta (nϭ6; Figure 5A ). In contrast, expression of KCNQ5 increased by 1.5-fold (nϭ4; Figure 5A ). Because the level of KCNQ4 mRNA was decreased in SHR thoracic aorta compared with normotensive rat aorta, we investigated whether this difference was translated at the protein level. Reactive bands (from the same membrane) that corresponded to the theoretical molecular weight of Kv7.4 and ␤-actin were identified in the protein lysates from thoracic aorta and mesenteric artery of normo- tensive rats and SHRs ( Figure 5B ). Protein bands that corresponded to Kv7.4 were normalized to their respective anti-␤-actin band, and intensity of bands in normotensive rat versus SHR tissue was compared. In the thoracic aorta, the density of bands in SHRs for Kv7.4 was 48.4Ϯ11.7% less than their respective normotensive rat Kv7.4 bands (nϭ3; Figure 5C ). A similar decrease in Kv7.4 protein expression from SHRs was also observed in the mesenteric arteries ( Figure 5C ).
Ang II-Induced Mouse Model of Hypertension
To demonstrate that functional differences in Kv7 modulators and changes in Kv7.4 protein levels were not unique to the SHR model, we also investigated an Ang II-induced mouse model of hypertension. [32] [33] [34] After 7 and 28 days, the systolic blood pressure of the saline-infused (sham) mice was 97.6Ϯ1.94 and 96.6Ϯ2.08 mm Hg, respectively (nϭ5 to 8), compared with 143.8Ϯ1.37 and 143.6Ϯ0.75 mm Hg (nϭ3 to 8), respectively, for mice that received Ang II. Figure 6 shows that the mean effect of S-1 (1, 3, and 10 mol/L) was attenuated significantly in the mesenteric arteries of the Ang II-infused mice at all concentrations compared with the sham mice ( Figure 6A ). In addition, the mesenteric arteries from 28-day Ang II-infused mice were less responsive to S-1 than the 7-day Ang II-infused mice at all concentrations ( Figure  6A ), although this did not reach significance at any concen- tration with the Mann-Whitney test. Similar to the findings in the rat vasculature, the density of the protein bands that corresponded to Kv7.4 (normalized to ␤-actin) in the mouse mesenteric lysates was decreased by Ϸ40% in 28-day Ang II-infused mice compared with saline-infused mice ( Figure  6B ). Kv7.4 band density was also less in the 7-day Ang II-infused mice than in saline-infused mice, although the difference was not as marked as with the 28-day-infused vessels ( Figure 6C ).
Discussion
Through the use of a number of different Kv7 activators, the present study has consolidated the emerging view that voltage-gated K ϩ channels encoded by KCNQ genes (Kv7 channels) are effective suppressors of vascular smooth muscle contractility. [13] [14] [15] [16] [17] [18] In addition, we now show that activation of Kv7 channels is a very effective mechanism to improve coronary perfusion, which suggests a potential role for these channels as targets in patients with coronary artery diseases such as unstable angina pectoris. However, the most striking revelation was the finding that the functional impact of vascular Kv7 channels was dramatically reduced in animal models of primary and secondary hypertension from 2 different species. Thus, the relaxant effects of the Kv7 activators S-1, BMS-204352, and retigabine were diminished consider- Figure 4 . Effect of Kv7 modulators on outward K ϩ currents in single myocytes from normotensive rat (NT) and spontaneously hypertensive rat (SHR) mesenteric artery. A, Representative traces of currents evoked by 500 ms depolarizing steps in myocytes from NTs (i) and SHRs (ii) in absence and presence of 10 mol/L S-1. B, Current-voltage relationships in absence and presence of 10 mol/L S-1 for normotensive rats (Bi; nϭ18, 3 rats) and SHRs (Bii; nϭ20, 3 rats). C, Currentvoltage relationship for S-1-sensitive outward current in normotensive rats and SHRs, obtained as a mean of the difference of the current peak amplitudes between currents in the absence and presence of S-1. D and E, Representative currents and mean current-voltage relationships in absence and presence of 10 mol/L XE991 for myocytes from normotensive rats (Di and Ei; nϭ11, 2 rats) or SHRs (Dii and Eii; nϭ11, 2 rats). F, Current-voltage relationship for the XE991-sensitive outward current in normotensive rats and SHRs. For each current-voltage relationship, currents in the presence of S-1 or XE991 were normalized to the current peak amplitude of the corresponding currents before the drug application. All statistical comparisons were made with an unpaired Student t test. *PϽ0.05, **PϽ0.01, and ***PϽ0.001. ably in blood vessels from SHRs and Ang II-induced hypertensive mice, which correlated with a reduced ability of S-1 to enhance K ϩ currents in rat mesenteric artery myocytes. In addition, Kv7 activators had a negligible effect on coronary flow from the isolated heart of an SHR, and Kv7 blockers produced markedly smaller contractions in the SHR thoracic aorta than in that of the normotensive rat. Interestingly, the ability of flupirtine, a Kv7 activator structurally similar to retigabine, to relax precontracted pulmonary arteries was attenuated in a mouse genetic model of pulmonary artery hypertension, although that study did not investigate any molecular changes in Kv7 channels. 35 In contrast, the present study shows that the dramatic attenuation of Kv7 function in SHRs was associated with a considerable reduction in KCNQ4 expression, with negligible changes detected in the other KCNQ isoforms. Subsequent probing for Kv7.4 in protein lysates from the SHR and Ang II-induced hypertensive mouse model demonstrated a considerable reduction in Kv7.4 levels in the aorta and mesenteric arteries. It was notable that there was a greater reduction of Kv7.4 protein levels and decrease in S-1-mediated relaxation in the hypertensive mice after 28 days of infusion of Ang-II than after 7 days of infusion, even though the increase in systolic blood pressure was identical. This suggests that the Kv7 response is impaired as a consequence of the hypertensive state, which would contribute to the maintenance of raised blood pressure, rather than a precipitator of hypertension.
Previous reports on the expression and function of Kv channels in the systemic vasculature during hypertension have been conflicting, and as such, a pathophysiological role for Kv channels in hypertension remains poorly defined. Expression of Kv1.2, Kv1.5, and Kv2.1 in systemic vessels such as the aorta or mesenteric artery appears to be unaffected or increased in hypertensive animals. 36, 37 This often equates to an increase in the level of channel protein and usually an increase in the Kv currents in these cells, although in cerebral arteries, Kv activity appears to be diminished, in correlation with a reduced amount of Kv1.2, Kv1.5, and Kv2.1 protein, as well as decreased Kv currents. 38 Hypertensive models also exhibit decreased BK Ca channel activity, but this appears to be due to a downregulation of the auxiliary ␤ 1 -subunit that leads to uncoupling from the activating Ca 2ϩ increment rather than to modified expression of the ␣-subunit. 39 -42 Compared with these subtle and varied responses in other Kv and BK Ca channels, the present study shows the reduction in the functional impact of Kv7 channels is dramatic and appears to be a feature of blood vessels throughout both the primary and secondary hypertensive vasculature.
Kv7 channels have an important physiological role in vascular tissues, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] as well as nonvascular tissues, [43] [44] [45] in addition to their established role in neurons, cardiomyocytes, and epithelia. In each vascular tissue studied previously, quantitative polymerase chain reaction and protein analysis revealed that KCNQ1, KCNQ4, and KCNQ5 were predominant, with a minimal contribution from KCNQ2 and KCNQ3. 14 -16,18 Ϫ⌬⌬Ct of relative abundance of KCNQ genes 1 through 5 in the thoracic aorta of the SHR compared with the normotensive rat. B, Representative Western blot for Kv7.4 expression in total protein lysates from normotensive rat (NT) and SHR thoracic aorta (TA) and mesenteric artery (MA) run on the same gel. The respective concentrations of protein loaded between normotensive rats and SHRs was identical, illustrated by the ␤-actin bands. C, Pixel densities of Kv7.4 bands normalized to their respective ␤-actin bands for NT and SHR (i) thoracic aorta (TA) and (ii) mesenteric artery (MA). Data are mean abundance of Kv7.4 normalized to corresponding ␤-actin level ϮSEM from 3 separate protein isolations (nϭ3). *PϽ0.05 according to unpaired Student t test.
Among the 3 dominantly expressed KCNQ genes, evidence has been accumulating that KCNQ4 and KCNQ5 expression products are the drivers of functional activity in the vasculature. Thus, although XE991 and linopirdine, which block all Kv7 isoforms, contract various rodent and human blood vessels (present study and References 13 and 15-18), Kv7.1-selective blockers have no effect functionally, even though the protein was present in the smooth muscle cells. 15 Moreover, the Kv7 activators that relax blood vessels 13, [15] [16] [17] [18] 26 do not affect Kv7.1 up to 100 mol/L (at 100 mol/L, inhibition of Kv7.1 is observed 23, 24 ). Furthermore, the present study showed that S-1 and BMS-204352, which are more efficacious activators of Kv7.4 and Kv7.5 than retigabine, 25, 31 were the most effective relaxants in thoracic aorta and mesenteric artery rings.
In coronary artery smooth muscle, very little is known regarding Kv channels 46 ; however, the present study revealed that Kv7 activators increased coronary flow considerably (Ϸ30%), with an effectiveness profile of BMS-204352ՆS-1Ͼ Ͼretigabine. The augmentation of coronary flow produced by Kv7 channel activators occurred at relatively low concentrations and was greater than that observed with ATPsensitive K ϩ channel openers such as pinacidil (Ϸ11% increase at 10 mol/L 47 ). Hence, Kv7 channels may offer a novel target for limiting cardiomyopathies due to coronary artery disease. However, in the hypertensive arteries, the ability of Kv7 activators to dilate coronary blood vessels was abrogated, in line with their in vitro effects on isolated blood vessels. This is in contrast to activators of ATP-sensitive K ϩ channels, which were more effective in SHR hearts (30% versus 11% increase 47 ). Regardless, the observed increase in coronary flow by Kv7 activators is an important addition to the cardiovascular profile of these agents. The present study not only provides an extensive comparison of different Kv7 activators in the vasculature and shows that Kv7 channels regulate coronary blood flow, but it also reveals that altered Kv7 activity may have a profound bearing on vascular pathophysiology. Although we demonstrate clearly that a depression of Kv7 activity and expression was concomitant with increased blood pressure, our experiments do not prove that a change in the expression of these channels is the primary cause of hypertension. However, the consequence of decreased Kv7 function will contribute to the progressive increase in arterial tone and raised total peripheral resistance that are manifest in hypertension. We do not know what initial factor has precipitated the decrease in KCNQ4 expression, but the striking and consistent attenuation in Kv7 function across different vascular beds provides important impetus to our understanding of the pathology of hypertension.
